TMDX TransMedics Group, Inc.

Develops a proprietary system for preserving human organs for transplant

$23.90  +1.85 (8.39%)
As of 12/07/2021 13:37:42 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  05/02/2019
Outstanding shares:  27,768,313
Average volume:  277,979
Market cap:   $601,183,976
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    89377M109
ISIN:        US89377M1099
Sedol:      BK6TM04
Valuation   (See tab for details)
PE ratio:   -16.17
PB ratio:   7.79
PS ratio:   21.30
Return on equity:   -48.20%
Net income %:   -134.15%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy